Stanford University |
Garry Nolan |
Basic Biology II |
Kinase signaling analysis of iPS cell reprogramming and differentiation |
$1,343,100 |
University of California, Irvine |
Peter Donovan |
Conference |
Systems Biology of Stem Cells |
$25,000 |
City of Hope, Beckman Research Institute |
Karen Aboody |
Disease Team Research I |
Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials |
$17,890,623 |
Stanford University |
Gary Steinberg |
Disease Team Research I |
Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke |
$17,244,851 |
University of California, Los Angeles |
Dennis Slamon |
Disease Team Research I |
Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors |
$19,979,660 |
University of California, Los Angeles |
Irvin Chen |
Early Translational from Disease Team Conversion |
Development of a humanized mouse model for testing anti-HIV HSPC gene therapy strategies in HIV-1 infected mice. |
$1,505,000 |
Calimmune, Inc. |
Geoff Symonds |
Disease Team Research I |
GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE |
$8,278,722 |
University of California, Los Angeles |
Donald Kohn |
Disease Team Research I |
Stem Cell Gene Therapy for Sickle Cell Disease |
$8,833,695 |
University of California, San Diego |
Lawrence Goldstein |
Early Translational from Disease Team Conversion |
Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis |
$4,139,754 |
Stanford University |
Irving Weissman |
Disease Team Research I |
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$18,759,276 |
ViaCyte, Inc. |
Allan Robins |
Disease Team Research I |
Cell Therapy for Diabetes |
$22,999,933 |
Cedars-Sinai Medical Center |
Eduardo Marbán |
Disease Team Research I |
Autologous cardiac-derived cells for advanced ischemic cardiomyopathy |
$5,560,232 |
City of Hope, Beckman Research Institute |
John Zaia |
Disease Team Research I |
ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS |
$14,536,969 |
University of California, Los Angeles |
Irvin Chen |
Disease Team Research I |
HPSC based therapy for HIV disease using RNAi to CCR5. |
$9,905,604 |
University of California, San Francisco |
Mitchel Berger |
Disease Team Research I |
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM) |
$6,214,914 |
University of Southern California |
Mark Humayun |
Disease Team Research I |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$18,904,916 |
University of California, San Diego |
Lawrence Goldstein |
Disease Team Research I |
Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis |
$5,694,308 |
University of California, San Diego |
Dennis Carson |
Disease Team Research I |
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) |
$19,999,826 |
Stanford University |
Alfred Lane |
Disease Team Research I |
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa |
$11,039,208 |
Sanford Consortium for Regenerative Medicine |
Edward Holmes |
Conference |
Stem Cell Meeting on the Mesa |
$40,000 |
University of Southern California |
Wange Lu |
Basic Biology I |
Defining the molecular mechanisms of somatic cell reprogramming |
$1,365,580 |
University of California, Los Angeles |
Luisa Iruela-Arispe |
Basic Biology I |
Molecular Characterization and Functional Exploration of Hemogenic Endothelium |
$1,371,477 |
University of California, Los Angeles |
Bennett Novitch |
Basic Biology I |
Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons |
$1,229,922 |
University of Southern California |
Martin Pera |
Basic Biology I |
The stem cell microenvironment in the maintenance of pluripotency and reprogramming |
$1,325,723 |
University of California, Los Angeles |
Michael Teitell |
Basic Biology I |
Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer |
$1,323,029 |
Stanford University |
Susan McConnell |
Basic Biology I |
Identification and characterization of human ES-derived DA neuronal subtypes |
$1,404,853 |
University of California, San Diego |
Eugene Yeo |
Basic Biology I |
RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency |
$1,308,901 |
Stanford University |
Julien Sage |
Basic Biology I |
The retinoblastoma (RB) gene family in cellular reprogramming |
$1,357,085 |
Stanford University |
Helen Blau |
Basic Biology I |
Molecular Mechanisms of Reprogramming towards Pluripotency |
$1,408,332 |
University of California, San Diego |
Karl Willert |
Basic Biology I |
WNT signaling and the control of cell fate decisions in human pluripotent stem cells. |
$1,329,298 |
University of California, Los Angeles |
Robb Maclellan |
Basic Biology I |
Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate |
$917,667 |
University of California, Davis |
Min Zhao |
Basic Biology I |
Directing migration of human stem cells with electric fields |
$816,228 |
City of Hope, Beckman Research Institute |
Richard Jove |
Conference |
Innovation and Translational Stem Cell Therapy for Diabetes and Neurological Diseases: Paving the way for real life solutions |
$14,878 |
University of California, San Francisco |
Arnold Kriegstein |
Conference |
UCSF Frontiers of Neural Stem Cells Symposium |
$35,000 |
Stanford University |
Hank Greely |
Conference |
Stem Cell Policy: Understanding the Scientific and Legal Challenges Ahead |
$5,838 |
University of California, Davis |
Alice Tarantal |
Early Translational I |
In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies |
$3,143,392 |
BioTime, Inc. |
Michael West |
Early Translational I |
Addressing the Cell Purity and Identity Bottleneck Through Generation and Expansion of Clonal Human Embryonic Progenitor Cell Lines |
$4,721,706 |
University of California, Davis |
Jan Nolta |
Early Translational I |
Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders |
$2,615,674 |
University of California, Irvine |
Frank LaFerla |
Early Translational I |
Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease |
$3,599,997 |
University of California, San Diego |
Yang Xu |
Early Translational I |
Developing induced pluripotent stem cells into human therapeutics and disease models |
$5,165,028 |
Scripps Research Institute |
Jeanne Loring |
Early Translational I |
Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation |
$5,830,771 |
ViaCyte, Inc. |
Olivia Kelly |
Early Translational I |
Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product |
$5,405,397 |
Scripps Health |
Darryl D'Lima |
Early Translational I |
Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis |
$3,118,431 |
Scripps Research Institute |
Martin Friedlander |
Early Translational I |
Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration |
$5,806,321 |
Gladstone Institutes, J. David |
Warner Greene |
Early Translational I |
Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation |
$1,280,001 |
Jackson Labs |
Pali Kaur |
Early Translational I |
Mouse Models for Stem Cell Therapeutic Development |
$3,759,134 |
Parkinson's Institute |
J. William Langston |
Early Translational I |
Using patient-specific iPSC derived dopaminergic neurons to overcome a major bottleneck in Parkinson's disease research and drug discovery |
$3,698,646 |
Stanford University |
Jill Helms |
Early Translational I |
Enhancing healing via Wnt-protein mediated activation of endogenous stem cells |
$6,464,126 |
University of California, Los Angeles |
Gabriel Travis |
Early Translational I |
Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration |
$5,487,136 |
Salk Institute for Biological Studies |
Inder Verma |
Early Translational I |
Curing Hematological Diseases |
$5,979,252 |
Sanford Burnham Prebys Medical Discovery Institute |
Evan Snyder |
Early Translational I |
Developmental Candidates for Cell-Based Therapies for Parkinson's Disease (PD) |
$5,190,752 |
University of California, San Francisco |
Brian Black |
Conference |
Weinstein Cardiovascular Development Conference |
$35,000 |
University of California, San Diego |
Shu Chien |
Conference |
10th Annual UC Systemwide Bioengineering Symposium |
$8,000 |
University of California, San Diego |
Lawrence Goldstein |
Conference |
San Diego Stem Cell Science Education Symposium at UCSD |
$6,237 |
City of Hope, Beckman Research Institute |
Fouad Kandeel |
Conference |
2009 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Biology, Immunology and Cell Therapy |
$15,000 |
University of Southern California |
Robert Maxson |
Research Training II |
CIRM Stem Cell Biology Training Program |
$5,827,817 |
City College Of San Francisco |
Carin Zimmerman |
Bridges |
City College of San Francisco Stem Cell Training Enhancement Program |
$2,649,780 |
Sanford Burnham Prebys Medical Discovery Institute |
Alessandra Sacco |
Research Training II |
Type III CIRM Stem Cell Research Training Program |
$2,781,376 |
Humboldt State University |
Jacob Varkey |
Bridges |
The HSU CIRM Bridges to Stem Cell Research Certificate Program |
$3,195,858 |
University of California, Davis |
Frederick Meyers |
Research Training II |
UC Davis Stem Cell Training Program |
$4,838,291 |
Pasadena City College |
Pamela Eversole-Cire |
Bridges |
Bridges to Stem Cell Research at Pasadena City College |
$3,596,922 |
University of California, Berkeley |
Ellen Robey |
Research Training II |
Interdisciplinary Training in Stem Cell Biology, Engineering and Medicine |
$6,888,557 |
San Diego State University Foundation |
Ralph Feuer |
Bridges |
SDSU/CIRM Stem Cell Internship Program |
$4,156,315 |
Scripps Research Institute |
Ulrich Mueller |
Research Training II |
Training Stem Cell Researchers at the Chemistry-Biology Interface |
$3,697,326 |
San Francisco State University |
Carmen Domingo |
Bridges |
SFSU Bridges to Stem Cell Research |
$4,168,243 |
Children's Hospital of Los Angeles |
David Warburton |
Research Training II |
CHLA Stem Cell Training Grant |
$5,020,920 |
San Jose State University |
Tzvia Abramson |
Bridges |
San Jose State University Stem Cell Internships for Laboratory-based Learning (SJSU SCILL) |
$4,154,051 |
City of Hope, Beckman Research Institute |
Michael Barish |
Research Training II |
City of Hope Research Training Program in Stem Cell Biology |
$2,197,782 |
University of California, Los Angeles |
Kenneth Dorshkind |
Research Training II |
UCLA CIRM Research Training Program II |
$7,790,488 |
Berkeley City College |
Barbara Des Rochers |
Bridges |
Specialty in Stem Cell Biology |
$2,227,230 |
University of California, Santa Barbara |
Dennis Clegg |
Research Training II |
Training Program in Stem Cell Biology and Engineering |
$2,448,823 |
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo |
Trevor Cardinal |
Bridges |
Masters of Science Specialization in Stem Cell Technology |
$3,480,357 |
University of California, Irvine |
Peter Donovan |
Research Training II |
UCI-CIRM Research Training Program II |
$6,067,550 |
Cal Poly Pomona |
Jill Adler-Moore |
Bridges |
Cal Poly Pomona and Cal State LA Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education |
$3,056,191 |
University of California, San Francisco |
Susan Fisher |
Research Training II |
Training Program in Stem Cell Research at UCSF |
$7,814,027 |
Cal State Univ, Channel Island |
Nitika Parmar |
Bridges |
Curriculum Development and Implementation of Stem Cell Technology and Laboratory Management Emphasis in an Established MS Biotechnology and Bioinformatics Program at California State University Channel Islands and Co-development of a GE Course on Stem Cel |
$4,165,092 |
University of California, San Diego |
Sylvia Evans |
Research Training II |
Interdisciplinary Stem Cell Training Program at UCSD II |
$7,432,600 |
Cal State Univ, Fullerton |
Nilay Patel |
Bridges |
Stem Cell Training Program at CSU Fullerton - A Bridge to Stem Cell Research |
$2,764,079 |
Buck Institute for Age Research |
Xianmin Zeng |
Research Training II |
CIRM Research Training Program in Stem Cells and Aging |
$1,472,416 |
Cal State Univ, Long Beach |
Lisa Klig |
Bridges |
CIRM Stem Cell Research Biotechnology Training Program at CSULB |
$3,487,091 |
University of California, Santa Cruz |
David Haussler |
Research Training II |
UCSC CIRM Training Program in Systems Biology of Stem cells |
$4,397,002 |
Cal State Univ, Northridge |
Cindy Malone |
Bridges |
CSUN-UCLA Bridges to Stem Cell Research |
$3,814,078 |
Reza Ardehali |
Reza Ardehali |
New Faculty Physician Scientist |
Medical School Loan Repayment Program |
$35,511 |
Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Research Training II |
Training in the Biology of Human Embryonic Stem Cells and Emerging Technologies II |
$2,886,221 |
Cal State Univ, Sacramento |
Lisa Hammersley |
Bridges |
Strengthening the Pipeline of Masters-level Scientific and Laboratory Personnel in Stem Cell Research |
$3,057,754 |
Ali Nsair |
Ali Nsair |
New Faculty Physician Scientist |
Medical School Loan Repayment Program |
$120,312 |
Stanford University |
Theo Palmer |
Research Training II |
Stanford CIRM Training Program |
$7,017,629 |
Cal State Univ, San Bernadino |
Nicole Bournias-Vardiabasis |
Bridges |
CSUSB Bridges to Stem Cell Research |
$2,762,085 |
Tippi C. Mackenzie |
Tippi Mackenzie |
New Faculty Physician Scientist |
Medical School Loan Repayment Program |
$36,436 |
Gladstone Institutes, J. David |
Robert Mahley |
Research Training II |
Gladstone CIRM Scholars Program |
$4,869,300 |
Cal State Univ, San Marcos |
Bianca Mothe |
Bridges |
California State University-San Marcos CIRM Bridges to the Stem Cell Research Training Grant |
$4,114,712 |
City of Hope, Beckman Research Institute |
Larry Couture |
Tools and Technologies I |
Development of Suspension Adaptation, Scale-up cGMP Banking and Cell Characterization Technologies for hESC Lines |
$882,929 |
University of California, San Diego |
Steve Dowdy |
Tools and Technologies I |
TAT Cell-Permeable Protein Delivery of siRNAs for Epigenetic Programming of Human Pluripotent and Adult Stem Cells |
$720,000 |
University of California, Irvine |
Lisa Flanagan |
Tools and Technologies I |
Novel Separation of Stem Cell Subpopulations |
$861,122 |
ViaCyte, Inc. |
Evert Kroon |
Tools and Technologies I |
Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors. |
$827,072 |
University of California, Santa Cruz |
Joel Kubby |
Tools and Technologies I |
AO Wide-Field Microscope |
$549,551 |
Stanford University |
Helen Blau |
Tools and Technologies I |
Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells |
$949,608 |
University of California, Davis |
Kit Lam |
Tools and Technologies I |
Discovery of adhesion ligands for pluripotent human stem cells |
$834,003 |
VistaGen Therapeutics, Inc. |
Kristina Bonham |
Tools and Technologies I |
Development of an hES Cell-Based Assay System for Hepatocyte Differentiation Studies and Predictive Toxicology Drug Screening |
$971,558 |
Scripps Research Institute |
Carlos Barbas |
Tools and Technologies I |
Development of a novel technology for precise, efficient, and safe genetic modification of stem cells |
$1,138,548 |